Vitamin D Receptor Agonists Target CXCL10: New Therapeutic Tools for Resolution of Inflammation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vitamin D Receptor Agonists Target CXCL10: New Therapeutic Tools for Resolution of Inflammation
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2013, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2013-04-18
DOI
10.1155/2013/876319
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective cohort study and review of the literature
- (2011) Yoav Arnson et al. AUTOIMMUNITY REVIEWS
- Vitamin D nutritional policy needs a vision for the future
- (2011) Anthony W Norman et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D3
- (2010) J. Wesley Pike et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system
- (2010) Femke Baeke et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes
- (2010) L. J. Dickie et al. RHEUMATOLOGY
- Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells
- (2010) Costanza Sagrinati et al. TRANSPLANT INTERNATIONAL
- Phenotypic and functional markers for 1α,25-dihydroxyvitamin D3-modified regulatory dendritic cells
- (2009) A. W. Pedersen et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Ligation of TLR9 induced on human IL-10–secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory function
- (2009) Zoë Urry et al. JOURNAL OF CLINICAL INVESTIGATION
- Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
- (2009) Mehran Ghoreishi et al. JOURNAL OF IMMUNOLOGY
- 1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3
- (2009) L. E. Jeffery et al. JOURNAL OF IMMUNOLOGY
- Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy
- (2009) Xiaoyue Tan et al. KIDNEY INTERNATIONAL
- Elocalcitol Inhibits Inflammatory Responses in Human Thyroid Cells and T Cells
- (2008) E. Borgogni et al. ENDOCRINOLOGY
- Immunosuppression in cardiac graft rejection: A human in vitro model to study the potential use of new immunomodulatory drugs
- (2008) Clara Crescioli et al. EXPERIMENTAL CELL RESEARCH
- Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells
- (2008) M. Sottili et al. EXPERIMENTAL CELL RESEARCH
- Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment
- (2008) Benedetta Mazzanti et al. JOURNAL OF NEUROIMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started